Avantor (NYSE:AVTR) Stock Bumped Up to Strong-Buy by Wall Street Zen

Wall Street Zen upgraded shares of Avantor (NYSE:AVTR) from a buy rating to a strong-buy rating in a research note released on Saturday morning,Wall Street Zen reports.

Several other equities research analysts have also issued reports on AVTR. Barclays lifted their price target on shares of Avantor from $15.00 to $16.00 and gave the company an “underweight” rating in a research note on Thursday, October 29th. Robert W. Baird raised their price objective on Avantor from $17.00 to $18.00 and gave the company an “outperform” rating in a report on Thursday, October 29th. UBS Group assumed coverage on Avantor in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $16.00 target price on the stock. Morgan Stanley lifted their target price on Avantor from $14.00 to $15.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 13th. Finally, Royal Bank Of Canada upped their target price on Avantor from $14.00 to $17.00 and gave the stock a “sector perform” rating in a report on Wednesday, October 28th. Two research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $14.77.

Avantor Stock Down 0.5%

Shares of AVTR stock traded down $0.07 on Friday, hitting $15.54. 6,819,433 shares of the stock were exchanged, compared to its average volume of 10,681,926. The company has a current ratio of 1.89, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $10.53 billion, a P/E ratio of 31.09, a price-to-earnings-growth ratio of 7.06 and a beta of 0.95. Avantor has a fifty-two week low of $7.26 and a fifty-two week high of $17.45. The business has a 50-day moving average of $15.70 and a 200 day moving average of $11.42.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, October 28th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. Avantor had a return on equity of 9.79% and a net margin of 5.08%. The business had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm earned $0.22 EPS. Avantor’s revenue for the quarter was up 4.6% compared to the same quarter last year. Equities analysts anticipate that Avantor will post 0.82 EPS for the current year.

Institutional Trading of Avantor

Large investors have recently added to or reduced their stakes in the company. Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Avantor during the 3rd quarter worth about $26,000. Elevation Wealth Partners LLC raised its holdings in shares of Avantor by 72.3% in the 3rd quarter. Elevation Wealth Partners LLC now owns 2,803 shares of the company’s stock valued at $42,000 after purchasing an additional 1,176 shares during the period. Meeder Asset Management Inc. acquired a new stake in Avantor in the 3rd quarter valued at about $56,000. Global Retirement Partners LLC lifted its stake in Avantor by 236.5% in the 3rd quarter. Global Retirement Partners LLC now owns 3,702 shares of the company’s stock valued at $56,000 after purchasing an additional 2,602 shares during the last quarter. Finally, Root Financial Partners LLC acquired a new stake in Avantor in the 3rd quarter valued at about $57,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc. is a global provider of products and services used in life sciences, advanced technology and applied materials. Its customers include biopharmaceutical and healthcare companies, laboratories, universities and manufacturers. The company supplies chemicals, reagents, laboratory consumables and equipment, as well as materials used in biopharmaceutical production. Avantor also provides services such as procurement, inventory management and support for laboratory and production operations.